Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
26 August 2020Website:
http://www.nuvationbio.comNext earnings report:
28 February 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Fri, 15 Nov 2024 23:55:28 GMTDividend
Analysts recommendations
Institutional Ownership
NUVB Latest News
NEW YORK--(BUSINESS WIRE)--Nuvation Bio Inc. (NYSE: NUVB), a late clinical-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology, today announced positive pooled data from the pivotal Phase 2 TRUST-I and TRUST-II studies evaluating taletrectinib, an investigational next-generation ROS1 TKI. The findings will be highlighted in a poster presentation on September 14, 2024, at the European Society of Medical Oncology (ESMO) Congress 2024 in Barcelona, Spain.
Does Nuvation Bio Inc. (NUVB) have what it takes to be a top stock pick for momentum investors? Let's find out.
What type of business is Nuvation Bio?
Nuvation Bio Inc., a clinical-stage biopharmaceutical company, focuses on the development of therapeutic candidates for oncology. The company's lead product candidate is NUV-868, a BD2 selective oral small molecule BET inhibitor that epigenetically regulates proteins that control tumor growth and differentiation, including oncogenes comprising c-myc; NUV-1156, an AR binder Xtandi that address advanced stage prostate cancers with the potential to move into earlier lines typically treated with surgical prostatectomy; and drug-drug conjugate (DDC) platform which leverages a novel therapeutic approach within the drug-conjugate class of anti-cancer therapies to deliver anti-cancer therapeutics to cancer cells, as well as NUV-1176, a PARP inhibitor to address ER+ breast and ovarian cancer. The company was founded in 2018 and is headquartered in New York, New York.
What sector is Nuvation Bio in?
Nuvation Bio is in the Healthcare sector
What industry is Nuvation Bio in?
Nuvation Bio is in the Biotechnology industry
What country is Nuvation Bio from?
Nuvation Bio is headquartered in United States
When did Nuvation Bio go public?
Nuvation Bio initial public offering (IPO) was on 26 August 2020
What is Nuvation Bio website?
https://www.nuvationbio.com
Is Nuvation Bio in the S&P 500?
No, Nuvation Bio is not included in the S&P 500 index
Is Nuvation Bio in the NASDAQ 100?
No, Nuvation Bio is not included in the NASDAQ 100 index
Is Nuvation Bio in the Dow Jones?
No, Nuvation Bio is not included in the Dow Jones index
When was Nuvation Bio the previous earnings report?
No data
When does Nuvation Bio earnings report?
The next expected earnings date for Nuvation Bio is 28 February 2025